Starch Medical Inc (SMI) announces the introduction of its advanced PerClot Laparoscopic hemostat in the European Union and other major international markets. PerClot Laparoscopic is a delivery configuration within the PerClot Polysaccharide Hemostatic System (PHS), was awarded CE approval in 2008. Perclot Laparoscopic is a hemostatic system which is designed for applications in minimally invasive surgical procedures. The Laparoscopic system contains a unique instrument for the precise delivery of AMP(Absorbable Modified Polymer) particles through the laparoscope to the bleeding site. The delivery instrument is easily attached to the PerClot bellows dispenser and this enables hemostat delivery under direct vision to the wound site for the control of venous, capillary and arterial bleeding. The laparoscopic system instrument can be employed in the working channel of a standard laparoscope for the delivery of AMP particles. Absorbable Modified Polymer (AMP) technology is a sophisticated engineering process which modifies plant starch into ultra-hydrophilic, adhesive forming hemostatic polymers. AMP materials are absorbable, biocompatible polysaccharides containing no human or animal components. PerClot Laparoscopic with other customized, minimally invasive instruments under development will be displayed at the 17th International Congress of the European Association for Endoscopic Surgery in Czech Republic.